Orphan receptor NR4A3 is a novel target of p53 that contributes to apoptosis

Area of Science:

• Molecular Biology
• Cancer Biology
• Genetics

Background:

• The p53 protein is a key tumor suppressor regulating genes involved in cell cycle, senescence, and apoptosis.
• The NR4A family of orphan receptors (NR4A1-3) are nuclear receptors influencing proliferation, cell migration, and apoptosis.

Purpose of the Study:

• To identify NR4A3 as a direct transcriptional target of p53.
• To investigate the functional role of NR4A3 in cancer cell proliferation and apoptosis.
• To explore the therapeutic potential of NR4A3 in cancer treatment.

Main Methods:

• ChIP-qPCR and luciferase reporter assays to confirm p53 binding to the NR4A3 promoter.
• Western blotting and qRT-PCR to analyze gene and protein expression levels.
• Cell proliferation assays, apoptosis assays, and Western blotting for Bcl-2 interaction studies.
• Bioinformatics analysis of patient data to correlate NR4A3 expression with survival rates.

Main Results:

• p53 directly binds to the NR4A3 promoter and induces its transcription.
• Overexpression of NR4A3 inhibits cancer cell proliferation and enhances apoptosis by upregulating PUMA and Bax.
• Knockdown of NR4A3 reverses these effects.
• NR4A3 interacts with Bcl-2, inhibiting its anti-apoptotic function.
• High NR4A3 expression correlates with improved survival in breast and lung cancer patients.

Conclusions:

• NR4A3 is a novel direct transcriptional target of p53.
• NR4A3 possesses tumor-suppressive functions by promoting apoptosis and inhibiting proliferation.
• NR4A3 represents a potential therapeutic target for breast and lung cancers.